Autoimmunity as the Body's Defense Mechanism Against the Enemy Within: Development of Therapeutic Vaccines for Neurodegenerative Disorders

References

• Aloisi F, Serafini B, et al (2000). Glia-T cell dialogue. JNeuroimmunol 107: 111–117.
   Google Scholar
• Asghar SS, Pasch MC (2000). Therapeutic inhibition of the complement system. Y2K update. Front Biosci 5: E63—E81.
   PubMed Web of Science ®Google Scholar
• Barouch R, Schwartz M (2002). Autoreactive T cells in-duce neurotrophin production by immune and neu-ral cells in injured rat optic nerve: implications for protective autoimmunity. FASEB J 16: 1304–1306.
   Google Scholar
• Ben-Nun A, Cohen IR (1982). Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: pro-cess of selection of lines and characterization of the cells. J Immuno1129: 303–308.
   Google Scholar
• Bjartmar C, Trapp BD (2001). Axonal and neuronal degener-ation in multiple sclerosis: mechanisms and functional consequences. Curr Opin Neuro114: 271–278.
   Google Scholar
• Burt RK, Marmont A, et al (2000). Intense immune sup-pression for systemic lupus-the role of hematopoietic stem cells. J Clin Immunol 20: 31–37.
   Google Scholar
• Butovsky O, Hauben E, et al (2001). Morphological aspects of spinal cord autoimmune neuroprotection: colocaliza-tion of T cells with B7-2 (CD86) and prevention of cyst formation. FASEB J15: 1065–1067.
   Google Scholar
• Choy EH (2000). Oral toleragens in rheumatoid arthritis. Curr Opin Invest Drugs 1: 58–62.
   Google Scholar
• Duda PW, Schmied MC, et al (2000). Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis. J Clin Invest 105: 967–976.
   PubMed Web of Science ®Google Scholar
• Farina C, Then Bergh F, et al (2001). Treatment of multiple sclerosis with Copaxone (COP): Elispot as-say detects COP-induced interleukin-4 and interferon-gamma response in blood cells. Brain 124: 705–719.
   PubMed Web of Science ®Google Scholar
• Fisher J, Levkovitch-Verbin H, et al (2001). Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies. J Neurosci 21: 136–142.
   PubMed Web of Science ®Google Scholar
• Greenamyre JT, MacKenzie G, et al (1999). Mitochondrial dysfunction in Parkinson's disease. Biochem Soc Symp 66: 85–97.
   PubMedGoogle Scholar
• Hartwick AT (2001). Beyond intraocular pressure: neuro-protective strategies for future glaucoma therapy. Optom Vis Sci 78: 85–94.
   PubMed Web of Science ®Google Scholar
• Hauben E, Butovsky O, et al (2000a). Passive or active im-munization with myelin basic protein promotes recov-ery from spinal cord contusion. J Neurosci 20: 6421–6430.
   PubMedGoogle Scholar
• Hauben E, Nevo U, et al (2000b). Autoimmune T cells as potential neuroprotective therapy for spinal cord injury. Lancet 355: 286–287.
   PubMed Web of Science ®Google Scholar
• Hovda DA, Yoshino A, et al (1991). Diffuse prolonged depression of cerebral oxidative metabolism following concussive brain injury in the rat: a cytochrome oxidase histochemistry study. Brain Res 567: 1–10.
   PubMed Web of Science ®Google Scholar
• Kim G, Kohyama K, et al (1998). Persistent expres-sion of experimental autoimmune encephalomyelitis (EAE)-specific Vbeta8.2 TCR spectra-type in the cen-tral nervous system of rats with chronic relapsing EAE. J Immuno1161: 6993–6998.
   Google Scholar
• Kipnis J, Hauben E, et al (2002a). Neuronal survival af-ter central nervous system injury is improved by deple-tion of CD4H-CD25+ regulatory T cells and worsened by neonatal tolerance to myelin proteins. Proc Nati Acad Sci USA In press.
   Google Scholar
• Kipnis J, Mizrahi T, et al (2002b). Myelin specific Th1 cells are necessary for post-traumatic protective autoi=u-nity. J Neuroimmunol 130: 78–850.
   PubMedGoogle Scholar
• Kipnis J, Yoles E, et al (2000). T cell immunity to copoly-mer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc Natl Acad Sci USA 97: 7446–7451.
   PubMed Web of Science ®Google Scholar
• Kipnis J, Yoles E, et al (2001). Neuronal survival after CNS insult is determined by a genetically encoded autoim-mune response. J Neurosci 21: 4564–4571.
   PubMedGoogle Scholar
• McMurray RW (2001). Bromocriptine in rheumatic and au-toimmune diseases. Semin Arthritis Rheum 31: 21–32.
   PubMed Web of Science ®Google Scholar
• Meyer R, Weissert R, et al (2001). Acute neuronal apopto-sis in a rat model of multiple sclerosis. J Neurosci 21: 6214–6220.
   PubMed Web of Science ®Google Scholar
• Mizrahi T, Hauben E, et al (2002). The tissue-specific self-pathogen is the protective self-antigen: the case of uveitis. J Immunol 169: 5971–5977.
   PubMedGoogle Scholar
• Moalem G, Leibowitz-Amit R, et al (1999). Autoi=une T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 5: 49–55.
   PubMed Web of Science ®Google Scholar
• Neuhaus O, Farina C, et al (2001). Mechanisms of action of glatiramer acetate in multiple sclerosis. Neurology 56: 702–708.
   PubMed Web of Science ®Google Scholar
• Neuhaus O, Farina C, et al (2000). Multiple sclerosis: com-parison of copolymer-1-reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells [In Process Citation]. Proc Nati Acad Sci USA 97: 7452–7457.
   PubMed Web of Science ®Google Scholar
• Olsson T, Dahlman I, et al (2000). Genetics of rat neuroin-fla=ation. J Neuroimmunol 107: 191–200.
   Google Scholar
• Owens T, Wekerle H, et al (2001). Genetic models for CNS inflammation. Nat Med 7: 161–166.
   PubMed Web of Science ®Google Scholar
• Perry VH, Anthony DC (1999). Axon damage and repair in multiple sclerosis. Philos Trans R Soc Lond B Biol Sci 354: 1641–1647.
   PubMed Web of Science ®Google Scholar
• Poluektova LY, Munn DH, et al (2002). Generation of cytotoxid T cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis. J Immuno1168: 3941–3949.
   Google Scholar
• Rothstein JD (1995a). Excitotoxic mechanisms in the patho-genesis of amyotrophic lateral sclerosis. Adv Neurol 68: 7–20.
   PubMedGoogle Scholar
• Rothstein JD (1995b). Excitotoxicity and neurodegenera-tion in amyotrophic lateral sclerosis. Clin Neurosci 3: 348–359.
   PubMedGoogle Scholar
• Schmidt S, Linington C, et al (1997). Multiple sclerosis: comparison of the human T-cell response to S100 beta and myelin basic protein reveals parallels to rat experi-mental autoimmune panencephalitis. Brain 120: 1437–1445.
   PubMed Web of Science ®Google Scholar
• Schori H, Kipnis J, et al (2001a). Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma. Proc Nati Acad Sci USA 98: 3398–3403.
   PubMed Web of Science ®Google Scholar
• Schori H, Yoles E, et al (2001b). T-cell-based immunity counteracts the potential toxicity of glutamate in the central nervous system. J Neuroimmunol 119: 199–204.
   Google Scholar
• Schwartz M (2001). Protective autoimmunity as a T-cell response to central nervous system trauma: prospects for therapeutic vaccines. Prog Neurobiol 65: 489–496.
   PubMed Web of Science ®Google Scholar
• Schwartz M, Kipnis J (2001). Protective autoi=unity: reg-ulation and prospects for vaccination after brain and spinal cord injuries. Trends Mol Med 7: 252–258.
   Google Scholar
• Schwartz M, Kipnis J (2002a). Autoi=unity on alert: nat-urally occurring regulatory CD4H-CD25+ T cells as part of the evolutionary compromise between a "need" and a "risk." Trends Immunol 23: 550–5548.
   Google Scholar
• Schwartz M, Kipnis J (2002b). Multiple sclerosis as a by-product of the failure to sustain protective autoimmu-nity: a paradigm shift. Neuroscientist 8: 405–430.
   PubMedGoogle Scholar
• Sela M (1999a). The concept of specific immune treatment against autoimmune diseases. Int Rev Immunol 18: 201–216.
   Google Scholar
• Sela M (1999b). Specific vaccines against autoimmune dis-eases [In Process Citation]. C R Acad Sci III 322: 933–938.
   Google Scholar
• Wimer BM (1998). Immunosuppressive applications of PHA and other plant mitogens. Cancer Mother Radio-pharmaco113: 99–107.
   Google Scholar
• Yoles E, Hauben E, et al (2001). Protective autoimmunity is a physiological response to CNS trauma. J Neurosci 21: 3740–3748.
   PubMed Web of Science ®Google Scholar
• Yoles E, Schwartz M (1998). Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathies. Exp Neurol 153: 1–7.
   PubMed Web of Science ®Google Scholar